China home to 200 mln hypertensive patients

China has more than 200 million hypertensive patients, according to Ma Xiaowei, an official at the National Health and Family Planning Commission of China.

China home to 200 mln hypertensive patients
2 Trillion potential market size in the healthcareindustry

Due to rising personal income and aging population, our healthcare industryhas entered into a rapid growing phase.In 2012, China\'surban household’s healthcare spending per capita has exceeded 1,000 y...

Biotech Pharm from Jan-Aug 2013 : Profit Growth Recovery, Steady Industry Growth From Jan - Aug 2013, the overall indust

From Jan – Aug 2013, the overall industrymaintained pretty steady growth with overall sales revenue of RMB1.27trillion,increased by 18.7% YoY (Year on Year); Net profits accounted for RMB122billion, ...

MNCs face more risk in China

China has become more and more important for manybulge bracket international pharmaceutical companies, however this entails morerisk. According to the latest report issued by McKinsey, it is expected ...

First-ever WHO prequalification for China vaccine firm

PATH and China National Biotec Group\'s SA 14-14-2 live, attenuated Japanese encephalitis (JE) vaccine was given prequalification status by the World Health Organization (WHO). The vaccine is manufactured by Chengdu Institute of Biological Products which is subsidiary of China Sino Biopharm Group.

Eight departments: jointly convention on regulation and execution of false advertising on illegal drugs, 16 Sep 2013

From 25 April to 25 July 2013, the National Industry and Commerce Administration, led eight relevant government departments, collaboratively, carried out a three-month special action towards illegal advertisements. Up until now, they dealt with 6903 illegal medical advertisement cases, and fined RMB62.27 million.

Total 6 Pages  First page  Page up  Page down  Last page


  • 2014
  • 2013
  • 2012